MyoKardia
Why Robinhood?
You can watch MyoKardia and buy or sell other stocks, ETFs, and their options commission-free!About MYOK
MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM).
MYOK Key Statistics
Stock Snapshot
MyoKardia(MYOK) stock is priced at $224.91, giving the company a market capitalization of 11.99B. It carries a P/E multiple of -39.87.
During the trading day, MyoKardia(MYOK) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.31M.
Over the past 52 weeks, MyoKardia(MYOK) stock has traded between a high of $225.00 and a low of $42.65.
Over the past 52 weeks, MyoKardia(MYOK) stock has traded between a high of $225.00 and a low of $42.65.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.